Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-300
Closed -$44K 3696
2016
Q4
$44K Hold
300
﹤0.01% 3664
2016
Q3
$50K Hold
300
﹤0.01% 3627
2016
Q2
$46K Hold
300
﹤0.01% 3662
2016
Q1
$45K Hold
300
﹤0.01% 3672
2015
Q4
$49K Hold
300
﹤0.01% 3698
2015
Q3
$41K Buy
+300
New +$47.3K ﹤0.01% 3748

Other funds holding AMGN

Invesco's AMGN Position: Q1 2026 in Review

Invesco reduced its Amgen (AMGN) stake by 5.9% in Q1 2026, selling an estimated $357M and leaving 15,885,506 shares worth $5.59B. The position accounts for 0.55% of the portfolio, ranked #26.

Invesco first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Invesco held 15,885,506 shares of Amgen worth $5.59B as of Q1 2026.
  • Invesco sold 1,000,580 Amgen shares in Q1 2026, an estimated $357M.
  • Amgen made up 0.55% of Invesco's portfolio in Q1 2026, its #26 holding.
  • Invesco first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.